Skip to main content

Table 2 Anthropometric data and clinical outcome of the study population

From: Suspicion of respiratory tract infection with multidrug-resistant Enterobacteriaceae: epidemiology and risk factors from a Paediatric Intensive Care Unit

  All (n = 123) MDR (n = 43) Susceptible (n = 80) p-value
Gestational age in weeks (median, [IQR]) 37 [34;39] 37 [34;39] 37 [33;39] 0.76
Birth weight (mean ± SD; kg) 2.62 ± 0.93 2.52 ± 1.05 2.67 ± 0.87 0.49
BMI (mean ± SD; kg/m2) 14.02 ± 4.21 13.65 ± 4.62 14.25 ± 3.95 0.47
Underlying diseases or conditions, n (%)
 Pulmonary 65 (53) 25 (58) 40 (50) 0.39
 Cardiosurgical 80 (65) 27 (63) 53 (66) 0.70
 Neurological 60 (50) 20 (47) 42 (53) 0.53
 Gastroenterological 61 (50) 26 (61) 35 (44) 0.08
 Hematooncological 10 (8) 3 (7) 7 (9) 0.73
 Immunodeficiency 4 (3) 4 (9) 0 (0) 0.006
CVC in place, n (%) 62 (66) 24 (55) 38 (48) 0.48
CVC days (median, [IQR]) 2.5 [0;8] 3 [0;9] 2 [0;7] 0.36
Days of antibiotic pre-exposurea (median, [IQR]) 2 [0;7] 4 [0;9] 2 [0;5] 0.2
Ventilated days (median, [IQR]) 7 [3;18] 6 [3;19] 8 [2;16] 0.91
PICU length of stay (median, [IQR]) 14 [7;32] 14 [6;32] 14.5 [7;33] 0.89
VAP Incidence, n (%) 18 (15) 9 (21) 9 (11) 0.15
All-cause mortality, 6 months, n (%) 17 (14) 8 (20) 9 (11) 0.22
  1. Anthropometric data and clinical outcome of the study population of 123 intubated children with Enterobacteriaceae in tracheal aspirates. Comparison between patients with MDR (n = 43) and susceptible (n = 80) isolates. MDR Multidrug-resistant Enterobacteriaceae, PICU Paediatric Intensive Care Unit, IQR Interquartile Range, BMI body mass index, CVC central venous catheter, VAP ventilator-associated pneumonia
  2. aDuration of antibiotic therapy up to 4 weeks prior to culture in days